Implementation of Population Breast Cancer Genetic Services in Federally Qualified Health Centers (FQHC) (TestMiGenes)
Hereditary Cancer Syndrome
About this trial
This is an interventional prevention trial for Hereditary Cancer Syndrome
Eligibility Criteria
Aim 1 and 2 Inclusion Criteria for patients Adults age 25+ English speaking Self identifies race as African American or Black Identified as eligible for cancer genetic testing for a hereditary breast or colon cancer syndrome (e.g., BRCA, Lynch or familial polyposis syndrome) as defined by NCCN criteria45-46 Screened positive and agreed to have study staff contact them in the future to participate in virtual/telephone interviews about their experiences with cancer genetics services. Patient receiving care from one of the 2 Mile Square Health Centers enrolled in the clinical trial Exclusion Criteria: Did not meet the inclusion criteria Did not screen positive on HCRA and/ or did not agree to have study staff contact them in the future to participate in virtual/telephone interviews about their experiences with cancer genetics services. Not a patient receiving care from the Mile Square Health Centers enrolled in the clincial trial Aim 2 Inclusion Criteria for Providers/Staff: Provider or staff member at one of the 2 MSHC clinics enrolled in the clinical trial English speaking Exclusion Criteria: 1. Does not meet inclusion criteria above
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
MGT (Mainstream Genetic Testing) Model
SOC (Standard of Care) Model
The mainstream genetic testing (MGT) model of cancer genetic services involves a non-genetics healthcare provider, such as the primary care provider, who engages patients in the counseling, consenting, and ordering of genetic testing. The provider/care team discloses the genetic test results and refers patients for genetic counseling only when genetic test results are abnormal. By eliminating the pre- and post-test counseling visits with a genetics provider, the MGT model has the potential to provide scalable access to genetic services.
The enhanced standard of care model (SOC+) is the current referral model of cancer genetic services delivery with an enhancement to include screening for and resources to address health literacy. This model begins with a health care provider's recognition, identification and then referral of a patient to a genetic counselor where genetic testing takes place if appropriate. This model is time- and resource- intensive and may not be scalable.